Sep 10, 2026 08:03AM
Sep 10, 2026 08:00AM
Sep 9, 2026 08:00AM
Aug 20, 2026 08:00AM
Aug 12, 2026 07:30AM
Jul 14, 2026 06:44AM
May 12, 2026 08:30AM Adagene to Participate in Two Upcoming Investor Conferences
Apr 17, 2026 04:01PM
Apr 17, 2026 04:01PM
Apr 14, 2026 07:01AM
Apr 14, 2026 07:00AM
Apr 7, 2026 07:49AM
Apr 2, 2026 07:01AM
Apr 2, 2026 07:01AM Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable
Apr 2, 2026 07:00AM
Apr 2, 2026 07:00AM
Apr 1, 2026 05:00PM
Mar 17, 2026 04:35PM
Mar 10, 2026 05:31PM
Feb 17, 2026 09:27AM
Jan 23, 2026 08:00AM Adagene Provides Business Update and 2026 Objectives
Dec 16, 2025 07:00AM
Dec 16, 2025 07:00AM
Oct 31, 2025 07:00AM
Oct 31, 2025 07:00AM
Sep 3, 2025 09:05AM
Sep 3, 2025 09:05AM
Aug 15, 2025 06:53AM Adagene Inc (ADAG) PT Lowered to $7 at H.C. Wainwright
Aug 12, 2025 04:05PM
Jul 15, 2025 07:01AM
Jul 15, 2025 07:00AM
Mar 24, 2025 08:00AM
Sep 16, 2024 03:01AM
Feb 9, 2024 06:01AM
Feb 9, 2024 06:00AM Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further
Jan 9, 2023 07:02AM
Jan 9, 2023 07:00AM
Jan 9, 2023 07:00AM
Dec 16, 2022 06:32AM
Dec 16, 2022 06:30AM
Dec 16, 2022 06:30AM
Mar 31, 2022 08:30AM Adagene Reports Full Year 2021 Financial Results and Provides Corporate Update
Mar 31, 2022 08:30AM
Mar 16, 2022 07:00AM
Mar 16, 2022 07:00AM
Feb 2, 2022 04:23PM
Feb 2, 2022 04:05PM
Nov 30, 2021 09:28AM
Nov 29, 2021 06:03PM After-Hours Movers 11/29: (CPIX) (ADAG) (OM) Higher; (LIZI) (INTU) Lower (more...)
Nov 29, 2021 04:06PM

330,674 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All